Li-Fraumeni syndrome in adult patients with acute lymphoblastic leukemia

被引:0
作者
Zarubina, Kseniia, I [1 ]
Parovichnikova, Elena N. [1 ]
Surin, Vadim L. [1 ]
Pshenichnikova, Olesia S. [1 ]
Gavrilina, Olga A. [1 ]
Isinova, Galina A. [1 ]
Troitskaya, Vera V. [1 ]
Sokolov, Andrei N. [1 ]
Galtseva, Irina, V [1 ]
Kapranov, Nikolai M. [1 ]
Davydova, Juliia O. [1 ]
Obukhova, Tatiana N. [1 ]
Nikulina, Elena E. [1 ]
Sudarikov, Andrei B. [1 ]
Savchenko, Valerii G. [1 ]
机构
[1] Natl Res Ctr Hematol, Moscow, Russia
关键词
acute lymphoblastic leukemia; hereditary predisposition; Li-Fraumeni syndrome; TP53; mutations; CANCER-RISK; HEMATOLOGIC MALIGNANCIES; BREAST-CANCER; MUTATIONS; PREDISPOSITION; CHILDREN; MOTHERS;
D O I
10.26442/00403660.2021.07.200913
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Li-Fraumeni syndrome (LFS) is a rare, autosomal dominant, hereditary disorder that is characterized by an increased risk for certain types of cancer, acute lymphoblastic leukemia (ALL), particularly. Germline TP53 mutations are associated with LFS. Genetic counseling and follow-up is essential for patients with LFS and their relatives. Special therapeutic approaches are needed for treatment of oncological disease in these patients. The article presents a series of clinical cases of patients with ALL and SLF, considers general issues of diagnosis and treatment of adult patients with this hereditary genetic syndrome. Aim. Describe clinical observations of patients with acute lymphoblastic leukemia (ALL) and LFS and consider general issues of diagnosis and treatment of adult patients with LFS and ALL. Materials and methods. TP53 gene mutations were screened using Sanger sequencing in 180 de novo patients with Ph-negative (B- and T-cell) and Ph-positive ALL treated by Russian multicenter protocols (ALL-2009, ALL-2012, ALL-2016) at the National Research Center for Hematology, Moscow, Russia, and at the hematology departments of regional clinics of Russia (multicenter study participants). Results. TP53 gene mutations were found in 7.8% (n=14) of de novo ALL patients. In patients, whose biological material was available TP53 gene mutational status was determined in non-tumor cells (bone marrow and peripheral blood during remission, bone marrow samples after allogeneic hematopoietic stem cells transplantation and in tissue of non-hematopoietic origin) for discriminating germline mutations. The analysis included 5 patients (out of 14 with TP53 mutations), whose non-tumor biological material was available for research. Germline status was confirmed in 4 out of 5 - B-cell ALL (n=3), T-cell ALL (n=1) - investigated patients. Conclusion. Practical value of the research is the observation that the greater part of TP53 gene mutations in patients with Ph-negative B-cell ALL are germinal and associated with LFS.
引用
收藏
页码:763 / 769
页数:7
相关论文
共 50 条
  • [21] The importance of Li-Fraumeni syndrome, a hereditary cancer predisposition disorder
    Miranda Alcalde, Belen
    Villa Alcazar, Marta
    Martinez Romera, Isabel
    Lopez Ibor, Blanca
    [J]. ARCHIVOS ARGENTINOS DE PEDIATRIA, 2021, 119 (01): : E11 - E17
  • [22] Breast cancer patients suggestive of Li-Fraumeni syndrome: mutational spectrum, candidate genes, and unexplained heredity
    Penkert, Judith
    Schmidt, Gunnar
    Hofmann, Winfried
    Schubert, Stephanie
    Schieck, Maximilian
    Auber, Bernd
    Ripperger, Tim
    Hackmann, Karl
    Sturm, Marc
    Prokisch, Holger
    Hille-Betz, Ursula
    Mark, Dorothea
    Illig, Thomas
    Schlegelberger, Brigitte
    Steinemann, Doris
    [J]. BREAST CANCER RESEARCH, 2018, 20
  • [23] Unusual relapse of low hypodiploid acute lymphoblastic leukaemia in a family with Li-Fraumeni syndrome
    van Delft, Frederik W.
    Bailey, Simon
    Skinner, Roderick
    Shenton, Geoff
    Carey, Peter
    Campbell-Hewson, Quentin
    Hale, Juliet
    McDonald, Leigh
    Pearce, Kate
    Martin, Richard
    Robinson, Katrina
    Cuthbert, Gavin
    [J]. PEDIATRIC BLOOD & CANCER, 2023, 70 (09)
  • [24] Li-Fraumeni and Li-Fraumeni-Like Syndrome Among Children Diagnosed With Pediatric Cancer in Southern Brazil
    Giacomazzi, Juliana
    Selistre, Simone G.
    Rossi, Cristina
    Alemar, Barbara
    Santos-Silva, Patricia
    Pereira, Fernando S.
    Netto, Cristina B.
    Cossio, Silvia L.
    Roth, Daniela E.
    Brunetto, Algemir L.
    Zagonel-Oliveira, Marcelo
    Martel-Planche, Ghyslaine
    Goldim, Jose R.
    Hainaut, Pierre
    Camey, Suzi A.
    Ashton-Prolla, Patricia
    [J]. CANCER, 2013, 119 (24) : 4341 - 4349
  • [25] Li-Fraumeni syndrome heterogeneity
    Gargallo, P.
    Yanez, Y.
    Segura, V.
    Juan, A.
    Torres, B.
    Balaguer, J.
    Oltra, S.
    Castel, V.
    Canete, A.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (07) : 978 - 988
  • [26] Li-Fraumeni Syndrome and the Role of the Pediatric Nurse Practitioner
    Parsons, Melissa
    [J]. CLINICAL JOURNAL OF ONCOLOGY NURSING, 2011, 15 (01) : 79 - 87
  • [27] Update on Li-Fraumeni syndrome
    Dutzmann, C. M.
    Vogel, J.
    Kratz, C. P.
    Pajtler, K. W.
    Pfister, S. M.
    Doergeloh, B. B.
    [J]. PATHOLOGE, 2019, 40 (06): : 592 - 599
  • [28] Frequent occurrence of gastric cancer in Asian kindreds with Li-Fraumeni syndrome
    Ariffin, H.
    Chan, A. S. L.
    Oh, L.
    Abd-Ghafar, S.
    Ong, G. B.
    Mohamed, M.
    Razali, H.
    Juraida, E.
    Teo, S. H.
    Karsa, M.
    Shamsani, J.
    Hainaut, P.
    [J]. CLINICAL GENETICS, 2015, 88 (05) : 450 - 455
  • [29] Epithelioid angiomyolipoma of the liver in a patient with Li-Fraumeni syndrome: a case report
    Yang, Yaewon
    Lee, Jisun
    Woo, Chang Gok
    Lee, Ok-Jun
    Son, Seung-Myoung
    [J]. DIAGNOSTIC PATHOLOGY, 2024, 19 (01)
  • [30] Childhood predictive genetic testing for Li-Fraumeni syndrome
    Evans, D. G.
    Lunt, P.
    Clancy, T.
    Eeles, R.
    [J]. FAMILIAL CANCER, 2010, 9 (01) : 65 - 69